ICPT Shares Rise After Patent Settlement With Amneal (NASDAQ:ICPT)

of Aeon

Shares of Intercept Pharmaceuticals (NASDAQ:ICPT) added ~8% on Wednesday after the biotech announced a deal with generics maker Amneal Pharmaceuticals (NYSE:AMRX) to resolve a patent dispute over the liver disease therapy Ocaliva.

The January 24 agreement aims to resolve a

Leave a Comment